A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancer

    4 Citationer (Scopus)

    Abstract

    To determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLTs) of concurrent chemoradiotherapy and cetuximab in patients with non-resectable locally advanced esophageal cancer.
    OriginalsprogEngelsk
    TidsskriftAnticancer Research
    Vol/bind32
    Udgave nummer9
    Sider (fra-til)4019-23
    Antal sider5
    ISSN0250-7005
    StatusUdgivet - 2012

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancer'. Sammen danner de et unikt fingeraftryk.

    Citationsformater